143 related articles for article (PubMed ID: 34537206)
21. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
Liao Y; Cao L; Wang F; Pang R
J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
[TBL] [Abstract][Full Text] [Related]
22. Exosome-derived miR-2682-5p suppresses cell viability and migration by HDAC1-silence-mediated upregulation of ADH1A in non-small cell lung cancer.
Mao G; Mu Z; Wu D
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S318-S330. PubMed ID: 34477002
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
He S; Li Z; Yu Y; Zeng Q; Cheng Y; Ji W; Xia W; Lu S
Exp Cell Res; 2019 Jun; 379(2):203-213. PubMed ID: 30978341
[TBL] [Abstract][Full Text] [Related]
24. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
Wang P; Deng Y; Fu X
Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
26. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H
Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884
[TBL] [Abstract][Full Text] [Related]
27. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
28. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
Akgun S; Kucuksayan H; Ozes ON; Can O; Alikanoglu AS; Yildiz M; Akca H
Anticancer Agents Med Chem; 2019; 19(8):1058-1068. PubMed ID: 30727918
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.
Liu ZL; Wang H; Liu J; Wang ZX
Mol Cell Biochem; 2013 Jan; 372(1-2):35-45. PubMed ID: 22956424
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
31. miRNA-425-5p enhances lung cancer growth via the PTEN/PI3K/AKT signaling axis.
Zhou JS; Yang ZS; Cheng SY; Yu JH; Huang CJ; Feng Q
BMC Pulm Med; 2020 Aug; 20(1):223. PubMed ID: 32838785
[TBL] [Abstract][Full Text] [Related]
32. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
33. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
Li M; Luo R; Yang W; Zhou Z; Li C
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑28 promotes the proliferation of non‑small‑cell lung cancer cells by targeting PTEN.
Cui F; Zhou Q; Xiao K; Qian H
Mol Med Rep; 2020 Jun; 21(6):2589-2596. PubMed ID: 32236614
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
36. Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A.
Gu G; Hu C; Hui K; Zhang H; Chen T; Zhang X; Jiang X
Int J Nanomedicine; 2021; 16():6329-6343. PubMed ID: 34556984
[TBL] [Abstract][Full Text] [Related]
37. Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.
Shen H; Zhu F; Liu J; Xu T; Pei D; Wang R; Qian Y; Li Q; Wang L; Shi Z; Zheng J; Chen Q; Jiang B; Shu Y
PLoS One; 2014; 9(7):e103305. PubMed ID: 25058005
[TBL] [Abstract][Full Text] [Related]
38. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
39. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
Li M; Zhang S; Wu N; Wu L; Wang C; Lin Y
Sci Rep; 2016 Mar; 6():23100. PubMed ID: 26972445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
